Status:
UNKNOWN
Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Lung Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This work will focus on the anti-inflammatory and antioxidant pathways in lung diseases by measuring HO-1 in induced sputum and CO in exhaled air in cases of four respiratory diseases, asthma, chronic...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male and female
- Ages \>/= 18 years
- Diagnosed with one or more lung diseases
- Referred for sputum induction to the Pulmonary Laboratory in the Tel-Aviv Sourasky Medical Center
Exclusion
Key Trial Info
Start Date :
December 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01140685
Start Date
December 1 2009
Last Update
June 9 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.